Paul J. Sekhri

Paul J. Sekhri, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Veeva Systems Inc, Apnimed, Inc. and BiomX Inc. Between 17 June 2021 and 1 September 2026, the trades on record add up to 29 filings.

In open-market terms, that means 3 purchases worth €237k on one side and 3 sales worth €3.1M on the other. Taken together, the sales exceed the purchases by €2.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 22 option exercises. 2026 to date brings 1 purchase and no sales.

The median purchase comes to €42k. Clusters matter here: 1 out of 3 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 3 September 2026: an option exercise, in Veeva Systems Inc. The last purchase on record was published on 3 August 2026, which is 76 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.